Encyclopedia
ETHE1, persulfide dioxygenase
- genes
1. Normal Function
The ETHE1 gene provides instructions for making an enzyme that is active in mitochondria, which are the energy-producing centers in cells. The ETHE1 enzyme is part of a pathway that breaks down a molecule called sulfide (H2S) in mitochondria. Sulfide is produced in the body's tissues as part of normal cell processes, and it is also released by bacteria living in the gastrointestinal system (gut).
At low levels, sulfide is critical for normal cell functioning. However, this molecule becomes toxic at high levels, interfering with numerous cell activities. For example, excess sulfide interferes with mitochondrial energy production by blocking (inhibiting) an enzyme complex called cytochrome C oxidase (COX). This complex normally carries out one of the final steps in the process of energy production in mitochondria.
2. Health Conditions Related to Genetic Changes
2.1 Ethylmalonic Encephalopathy
More than 30 mutations in the ETHE1 gene have been identified in people with ethylmalonic encephalopathy. This rare condition affects many parts of the body, including the nervous system, blood vessels, and intestines. Signs and symptoms include delayed development, abnormal movements, rashes of tiny red spots under the skin (petechiae), blue discoloration of the hands and feet (acrocyanosis), and chronic diarrhea.
Most of the mutations that cause ethylmalonic encephalopathy lead to the production of nonfunctional versions of the ETHE1 enzyme or prevent cells from making any of this enzyme. A shortage of functional enzyme prevents sulfide from being broken down normally, allowing this molecule to accumulate in cells. The buildup of sulfide inhibits the activity of COX, which disrupts mitochondrial energy production and damages tissues and organs throughout the body. Researchers believe that the effects of excess sulfide in the brain, muscles, blood vessels, and lining of the intestines underlie most of the major features of ethylmalonic encephalopathy.
2.2 Leigh Syndrome
3. Other Names for This Gene
-
ETHE1_HUMAN
-
ethylmalonic encephalopathy 1
-
Ethylmalonic encephalopathy protein 1
-
hepatoma subtracted clone one
-
HSCO
-
YF13H12
This entry is adapted from the peer-reviewed paper https://medlineplus.gov/genetics/gene/ethe1
References
- Di Meo I, Fagiolari G, Prelle A, Viscomi C, Zeviani M, Tiranti V. Chronicexposure to sulfide causes accelerated degradation of cytochrome c oxidase inethylmalonic encephalopathy. Antioxid Redox Signal. 2011 Jul 15;15(2):353-62.doi: 10.1089/ars.2010.3520.
- Pettinati I, Brem J, McDonough MA, Schofield CJ. Crystal structure of humanpersulfide dioxygenase: structural basis of ethylmalonic encephalopathy. Hum Mol Genet. 2015 May 1;24(9):2458-69. doi: 10.1093/hmg/ddv007.
- Tiranti V, Briem E, Lamantea E, Mineri R, Papaleo E, De Gioia L, Forlani F,Rinaldo P, Dickson P, Abu-Libdeh B, Cindro-Heberle L, Owaidha M, Jack RM,Christensen E, Burlina A, Zeviani M. ETHE1 mutations are specific to ethylmalonicencephalopathy. J Med Genet. 2006 Apr;43(4):340-6.
- Tiranti V, D'Adamo P, Briem E, Ferrari G, Mineri R, Lamantea E, Mandel H,Balestri P, Garcia-Silva MT, Vollmer B, Rinaldo P, Hahn SH, Leonard J, Rahman S, Dionisi-Vici C, Garavaglia B, Gasparini P, Zeviani M. Ethylmalonic encephalopathyis caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet. 2004 Feb;74(2):239-52.
- Tiranti V, Viscomi C, Hildebrandt T, Di Meo I, Mineri R, Tiveron C, Levitt MD,Prelle A, Fagiolari G, Rimoldi M, Zeviani M. Loss of ETHE1, a mitochondrialdioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. NatMed. 2009 Feb;15(2):200-5. doi: 10.1038/nm.1907.Nat Med. 2009 Feb;15(2):220.
- Tiranti V, Zeviani M. Altered sulfide (H(2)S) metabolism in ethylmalonicencephalopathy. Cold Spring Harb Perspect Biol. 2013 Jan 1;5(1):a011437. doi:10.1101/cshperspect.a011437. Review.
